Quarterly report pursuant to Section 13 or 15(d)

4. Restatement of Condensed Consolidated Financial Statements

v3.20.2
4. Restatement of Condensed Consolidated Financial Statements
3 Months Ended
Jun. 30, 2020
Accounting Changes and Error Corrections [Abstract]  
Restatement of Condensed Consolidated Financial Statements

Note 4. Restatement of Condensed Consolidated Financial Statements (unaudited)  

 

Subsequent to filing of its Form 10-Q on August 14, 2020, the Company during the course of its review of the financial statements for September 30, 2020 identified several accounting issues which resulted in the overstatement of revenues and understatement of expenses during the three months ended June 30, 2020. These errors resulted in accounts receivable being overstated by $446,000, prepaid expenses being overstated by $123,000, accrued expenses being understated by $175,000 in the consolidated balance sheet in the Original Report. The errors further resulted in revenues being overstated by $1,487,000, cost of revenue being overstated by $779,000 and gross profit being overstated by $708,000, total operating expenses being understated by $75,000, other income (expense) being overstated $35,000, and income from discontinued operations being overstated 5,000 in the consolidated statements of comprehensive income (loss) in the Original Report. With the errors being corrected in this Amended Report, net income (loss) decreased by $753,000 to $240,000. Additionally, the changes resulted in a decrease of basic and diluted net income (loss) per common share of $0.41.

 

As a result, the Company restated its previously issued unaudited consolidated financial statements, included in its Amendment to the Company’s Quarterly Report on Form 10-Q/A for the three months ended June 30, 2020.

 

The following tables present the effects of the restatement on the Company’s condensed consolidated balance sheet as of June 30, 2020, the condensed consolidated statements of comprehensive income for the three months ended June 30, 2020 and the condensed consolidated cash flows for the three months ended June 30, 2020. In addition to the tables presented below, the Company’s accumulated deficit per the condensed consolidated statements of stockholders’ equity as of June 30, 2020 increased from ($171,253,000) to ($172,006,000) as a result of the decrease in net income from $993,000 to $240,000 for the three months ended June 30, 2020.

 

Condensed Consolidated Balance Sheet

 

    June 30, 2020  
    As Originally Reported     Adjustments     As Restated  
    (in thousands)     (in thousands)     (in thousands)  
ASSETS                  
Current assets:                        
Cash and cash equivalents   $ 4,551     $     $ 4,551  
Accounts receivable, net     5,220       (446 )     4,774  
Inventories, net     4,193             4,193  
Prepaid expenses and other current assets     2,937       (123 )     2,814  
Current portion of deferred consideration, net of discount     188             188  
Total current assets     17,089       (569 )     16,520  
Operating lease right-of-use assets     343             343  
Property and equipment, net     372             372  
Deferred consideration, net of discount, less current portion     779             779  
Other assets     69             69  
Total assets   $ 18,652     $ (569 )   $ 18,083  
                         
LIABILITIES AND STOCKHOLDERS’ EQUITY                        
Current liabilities:                        
Accounts payable   $ 4,133     $     $ 4,133  
Accrued expenses and other current liabilities     743       175       918  
Deferred revenue     150             150  
Deferred revenue Invekra     46             46  
Operating lease liabilities     135             135  
Current portion of long-term debt     265             265  
Total current liabilities     5,472       175       5,647  
Operating lease liabilities-non-current     220       1       221  
Long-term deferred revenue Invekra     240             240  
Long-term debt     1,310             1,310  
Total liabilities     7,242       176       7,418  
Commitments and Contingencies (Note 7)                        
Stockholders’ Equity                        
Convertible preferred stock, $0.0001 par value; 714,286 shares authorized at June 30, 2020 and March 31, 2020, respectively, 0 and 1.55 shares issued and outstanding at June 30, 2020 and March 31, 2020, respectively                  
Common stock, $0.0001 par value; 24,000,000 shares authorized at June 30, 2020 and March 31, 2020, 1,966,958 and 1,777,483 shares issued and outstanding at June 30, 2020 and March 31, 2020, respectively     2             2  
Additional paid-in capital     188,112             188,112  
Accumulated deficit     (171,253 )     (753 )     (172,006 )
Accumulated other comprehensive loss     (5,451 )     8       (5,443 )
Total stockholders’ equity     11,410       (745 )     10,665  
Total liabilities and stockholders’ equity   $ 18,652     $ (569 )   $ 18,083  

 

Condensed Consolidated Statement of Comprehensive Income (Loss)

 

    For the Three Months Ended June 30, 2020  
    As Originally Reported     Adjustments     As Restated  
    (in thousands)     (in thousands)     (in thousands)  
                   
Revenues   $ 7,254     $ (1,487 )   $ 5,767  
Cost of revenues     4,291       (779 )     3,512  
Gross profit     2,963       (708 )     2,255  
Operating expenses                        
Research and development     476             476  
Selling, general and administrative     2,369       75       2,444  
Total operating expenses     2,845       75       2,920  
Income (Loss) from operations     118       (783 )     (665 )
Interest expense     (2 )           (2 )
Interest income     2             2  
Other (expense) income, net     (156 )     35       (121 )
Gain on sale of assets     77             77  
Income (loss) from continuing operations   $ 39     $ (748 )   $ (709 )
Income from discontinued operations (Note 5)     954       (5 )     949  
Net income   $ 993     $ (753 )   $ 240  
                         
Net income per share: basic                        
Continuing operations   $ 0.02     $ (0.41 )   $ (0.39 )
Discontinued operations     0.52             0.52  
    $ 0.54     $ (0.41 )   $ 0.13  
Net income per share: diluted                        
Continuing operations   $ 0.02     $ (0.40 )   $ (0.38 )
Discontinued operations     0.52       (0.01 )     0.51  
    $ 0.54     $ (0.41 )   $ 0.13  
Weighted-average number of shares used in per common share calculations: basic     1,839             1,839  
Weighted-average number of shares used in per common share calculations: diluted     1,843             1,843  
                         
Other comprehensive income                        
Net income   $ 993     $ (753 )   $ 240  
Foreign currency translation adjustments     159       8       167  
Comprehensive income   $ 1,152     $ (745 )   $ 407  

 

Condensed Consolidated Statement of Cash Flows

 

    For the Three Months Ended June 30, 2020  
    As Originally Reported    

 

Adjustments

   

 

As Restated

 
    (in thousands)     (in thousands)     (in thousands)  
Cash flows from operating activities                        
Net income   $ 993     $ (753 )   $ 240  
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:                        
Depreciation and amortization     53             53  
Stock-based compensation     63             63  
Gain on sale of assets     (872 )           (872 )
Changes in operating assets and liabilities:                        
Accounts receivable     (724 )     446       (278 )
Inventories     (1,945 )           (1,945 )
Deferred consideration     31             31  
Prepaid expenses and other current assets     (323 )     123       (200 )
Operating lease right-of-use assets     49             49  
Accounts payable     1,660             1,660  
Accrued expenses and other current liabilities     (1,122 )     175       (947 )
Operating lease liabilities     (46 )           (46 )
Deferred revenue     (99 )           (99 )
Net cash (used in) provided by operating activities     (2,282 )     (9 )     (2,291 )
                         
Cash flows from investing activities:                        
Purchases of property and equipment     (52 )           (52 )
Deposits     (4 )           (4 )
Proceeds from sale of assets     610             610  
Net cash provided by (used in) investing activities     554             554  
                         
Cash flows from financing activities:                        
Proceeds from exercise of common stock purchase warrants     1,490             1,490  
Proceeds from new debt     1,310             1,310  
Principal payments on capital leases                  
Principal payments on long-term debt     (216 )           (216 )
Net cash provided by (used in) financing activities     2,584             2,584  
Effect of exchange rate on cash and cash equivalents     4       9       13  
Net increase in cash and cash equivalents     860             860  
Cash and cash equivalents, beginning of period     3,691             3,691  
Cash and cash equivalents, end of period   $ 4,551     $     $ 4,551  
                         
Supplemental disclosure of cash flow information:                        
Cash paid for interest   $ 2     $     $ 2